HeimNHIQ • OTCMKTS
add
NantHealth Inc
Við síðustu lokun
0,00010 $
Dagbil
0,00010 $ - 0,00010 $
Markaðsvirði
2,75 þ. USD
Meðalmagn
187,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
OTCMKTS
Viðskiptafréttir
BusinessLIVE
fyrir 5 klukkustundum
Nasdaq plunges to near six-month low as tariff slowdown fears mount
2,42%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Tekjur | 12,47 m. | — |
Rekstrarkostnaður | 12,17 m. | — |
Nettótekjur | -14,99 m. | — |
Hagnaðarhlutfall | -120,20 | — |
Hagnaður á hvern hlut | — | — |
EBITDA | -175,00 þ. | — |
Virkt skatthlutfall | -0,36% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 5,82 m. | — |
Heildareignir | 146,48 m. | — |
Heildarskuldir | 396,66 m. | — |
Eigið fé alls | -250,18 m. | — |
Útistandandi hlutabréf | 27,47 m. | — |
Eiginfjárgengi | -0,00 | — |
Arðsemi eigna | -8,24% | — |
Ávöxtun eigin fjár | -41,68% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2023info | Breyting á/á |
|---|---|---|
Nettótekjur | -14,99 m. | — |
Handbært fé frá rekstri | -7,65 m. | — |
Reiðufé frá fjárfestingum | 11,00 þ. | — |
Reiðufé frá fjármögnun | 7,50 m. | — |
Breyting á handbæru fé | -298,00 þ. | — |
Frjálst peningaflæði | -3,94 m. | — |
Um
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Framkvæmdastjóri
Stofnsett
7. júl. 2010
Vefsvæði
Starfsfólk
373
